These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 9800143)
1. Effects of beta-funaltrexamine on dose-effect curves for heroin self-administration in rats: comparison with alteration of [3H]DAMGO binding to rat brain sections. Martin TJ; DeMontis MG; Kim SA; Sizemore GM; Dworkin SI; Smith JE Drug Alcohol Depend; 1998 Oct; 52(2):135-47. PubMed ID: 9800143 [TBL] [Abstract][Full Text] [Related]
2. Differential involvement of mu-opioid receptors in the rostral versus caudal nucleus accumbens in the reinforcing effects of heroin in rats: evidence from focal injections of beta-funaltrexamine. Martin TJ; Kim SA; Lyupina Y; Smith JE Psychopharmacology (Berl); 2002 May; 161(2):152-9. PubMed ID: 11981595 [TBL] [Abstract][Full Text] [Related]
3. Alkylation of mu opioid receptors by beta-funaltrexamine in vivo: comparison of the effects on in situ binding and heroin self-administration in rats. Martin TJ; Dworkin SI; Smith JE J Pharmacol Exp Ther; 1995 Mar; 272(3):1135-40. PubMed ID: 7891326 [TBL] [Abstract][Full Text] [Related]
4. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
5. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats. Martin TJ; Kim SA; Cannon DG; Sizemore GM; Bian D; Porreca F; Smith JE J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849 [TBL] [Abstract][Full Text] [Related]
6. Effects of intracerebroventricular administration of beta-funaltrexamine on DAMGO-stimulated [35S]GTP-gamma-S binding in rat brain sections. Martin TJ; Sim LJ; Selley DE; deMontis MG; Childers SR Synapse; 1997 Nov; 27(3):177-82. PubMed ID: 9329153 [TBL] [Abstract][Full Text] [Related]
7. Effects of intracerebroventricular administration of beta-funaltrexamine on [3H]DAMGO binding to rat brain sections. Martin TJ; Dworkin SI; Smith JE J Pharmacol Exp Ther; 1993 Oct; 267(1):506-14. PubMed ID: 8229781 [TBL] [Abstract][Full Text] [Related]
8. Characteristics of dose-dependent antagonism by beta-funaltrexamine of the antinociceptive effects of intrathecal mu agonists. Mjanger E; Yaksh TL J Pharmacol Exp Ther; 1991 Aug; 258(2):544-50. PubMed ID: 1650833 [TBL] [Abstract][Full Text] [Related]
9. Effects of intracerebroventricular beta-funaltrexamine on mu and delta opioid receptors in the rat: dichotomy between binding and antinociception. Liu-Chen LY; Li SX; Wheeler-Aceto H; Cowan A Eur J Pharmacol; 1991 Oct; 203(2):195-202. PubMed ID: 1666046 [TBL] [Abstract][Full Text] [Related]
10. Involvement of the lateral amygdala in the antiallodynic and reinforcing effects of heroin in rats after peripheral nerve injury. Martin TJ; Buechler NL; Kim SA; Ewan EE; Xiao R; Childers SR Anesthesiology; 2011 Mar; 114(3):633-42. PubMed ID: 21293255 [TBL] [Abstract][Full Text] [Related]
11. Interactions among mu- and delta-opioid receptors, especially putative delta1- and delta2-opioid receptors, promote dopamine release in the nucleus accumbens. Hirose N; Murakawa K; Takada K; Oi Y; Suzuki T; Nagase H; Cools AR; Koshikawa N Neuroscience; 2005; 135(1):213-25. PubMed ID: 16111831 [TBL] [Abstract][Full Text] [Related]
12. Pretreatment of rats with the irreversible mu-receptor antagonist, beta-FNA, fails to prevent naltrexone-induced upregulation of mu-opioid receptors. Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW Neuropharmacology; 1990 Sep; 29(9):805-10. PubMed ID: 1963479 [TBL] [Abstract][Full Text] [Related]
13. Autoradiographic study of irreversible binding of [3H]beta-funaltrexamine to opioid receptors in the rat forebrain: comparison with mu and delta receptor distribution. Liu-Chen LY; Li SX; Lewis ME Brain Res; 1991 Mar; 544(2):235-42. PubMed ID: 1645609 [TBL] [Abstract][Full Text] [Related]
14. Micro-opioid receptor alkylation in the ventral pallidum and ventral tegmental area, but not in the nucleus accumbens, attenuates the effects of heroin on cocaine self-administration in rats. Martin TJ; Coller M; Co C; Smith JE Neuropsychopharmacology; 2008 Apr; 33(5):1171-8. PubMed ID: 17581528 [TBL] [Abstract][Full Text] [Related]
17. Cocaine and heroin ('speedball') self-administration: the involvement of nucleus accumbens dopamine and mu-opiate, but not delta-opiate receptors. Cornish JL; Lontos JM; Clemens KJ; McGregor IS Psychopharmacology (Berl); 2005 Jun; 180(1):21-32. PubMed ID: 15682301 [TBL] [Abstract][Full Text] [Related]
18. Mechanisms of mu opioid receptor/G-protein desensitization in brain by chronic heroin administration. Maher CE; Martin TJ; Childers SR Life Sci; 2005 Jul; 77(10):1140-54. PubMed ID: 15890372 [TBL] [Abstract][Full Text] [Related]
19. Differential desensitization of mu- and delta- opioid receptors in selected neural pathways following chronic morphine treatment. Noble F; Cox BM Br J Pharmacol; 1996 Jan; 117(1):161-9. PubMed ID: 8825358 [TBL] [Abstract][Full Text] [Related]
20. Effect of antagonists selective for mu, delta and kappa opioid receptors on the reinforcing effects of heroin in rats. Negus SS; Henriksen SJ; Mattox A; Pasternak GW; Portoghese PS; Takemori AE; Weinger MB; Koob GF J Pharmacol Exp Ther; 1993 Jun; 265(3):1245-52. PubMed ID: 8389859 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]